Rituximab for Secondary Progressive Multiple Sclerosis: A Case Series

By Rommer Paulus S.   Patejdl Robert   Winkelmann Alexander   Benecke Reiner   Zettl Uwe K.  

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 607-613

Adis International

Access to resources Recommend Favorite

Paclitaxel therapy is promising in secondary progressive multiple sclerosis

By  

Inpharma, Vol. 1, Iss. 1227, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Interferon- -1b: A Review of its Use in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

By McCormack P.L.   Scott L.J.  

CNS Drugs, Vol. 18, Iss. 8, 2004-01 ,pp. : 521-546

Adis International

Access to resources Recommend Favorite

Patients with secondary progressive multiple sclerosis (MS) may not benefit from treatment with IV immunoglobulin G (IVIG)

By  

Inpharma, Vol. 1, Iss. 1457, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

IFN- -1b delays deterioration in secondary-progressive MS

By  

Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite